The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples